Philip Morris International Inc
Change company Symbol lookup
Select an option...
PM Philip Morris International Inc
PRSRW Prospector Capital Equity Warrants 1st Jan 2025 *W EXP 01/01/2025
HYMCW Hycroft Mining Holding Equity Warrant Exp 29th May 2025 *W EXP 05/29/2025
NVOS Novo Integrated Sciences Inc
TEL TE Connectivity Ltd
NOTV Inotiv Inc
PLUG Plug Power Inc
WMT WALMART STORES INC
HZNP Horizon Therapeutics PLC
EXPE Expedia Group Inc
Go

Consumer Staples : Tobacco | Large Cap Value
Company profile

Philip Morris International Inc. (PMI) is an international tobacco company. It focuses on delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. Its product portfolio consists of cigarettes and smoke-free products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. It is engaged in developing smoke-free products for adults along with building scientific assessment capabilities in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. The United States Food and Drug Administration (FDA) has authorized versions of its IQOS Platform 1 device and consumables, and Swedish Match's General snus, as Modified Risk Tobacco Products (MRTPs). Its portfolio consists of both international and local brands and is led by Marlboro. Its other cigarette brands include Chesterfield, L&M and Philip Morris.

Premarket

Last Trade
Delayed
$92.00
0.38 (0.41%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$91.62
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
7

10-day average volume:
5,215,059
7

Company Profile

Philip Morris International Inc. (PMI) is an international tobacco company. It focuses on delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. Its product portfolio consists of cigarettes and smoke-free products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. It is engaged in developing smoke-free products for adults along with building scientific assessment capabilities in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. The United States Food and Drug Administration (FDA) has authorized versions of its IQOS Platform 1 device and consumables, and Swedish Match's General snus, as Modified Risk Tobacco Products (MRTPs). Its portfolio consists of both international and local brands and is led by Marlboro. Its other cigarette brands include Chesterfield, L&M and Philip Morris.

Valuation Ratios

Price/Earnings (TTM)
16.09x
Price/Sales (TTM)
4.36x
Price/Book (MRQ)
--
Price/Cash Flow (TTM)
13.76x
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend

Short Interest

May 2023
Current Month
7.0M
Previous Month
7.3M
Percent of Float
0.45%
Days to Cover
2.3577 Days

Share Information

PM is in a share class of common stock
Float
1.5B
Shares Outstanding
1.6B
Institutions Holding Shares
2,453
76.64%

Financial Statements

Balance sheet

Values displayed are in millions.

Income statement

Values displayed are in millions.

Cash flow

Values displayed are in millions.

Company Officers

  • Andre CalantzopoulosChmn.
  • Jacek OlczakCEO
  • Emmanuel BabeauCFO
  • Massimo AndolinaCorp.Exec.
  • Werner BarthCorp.Exec.

Address

Insider Trading

During the most recent quarter, 162K shares were sold in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.